Algovita Spinal Cord Stimulation System Hi-Fi Study



Status:Recruiting
Conditions:Chronic Pain, Chronic Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:18 - 75
Updated:4/4/2019
Start Date:November 2, 2018
End Date:July 2021
Contact:Hannah Bearinger
Email:hi-fi@brightresearchpartners.com
Phone:(612) 345-4544

Use our guide to learn which trials are right for you!

Clinical Trial Comparing Ultra-High Versus Traditional Pulse Widths Using the ALGOVITA® SCS System High Fidelity Stimulation in the Treatment of Persistent or Recurrent Back and/or Leg Pain Following Spinal Surgery

The objective of this study is to obtain post-market clinical outcome data for the Algovita
SCS System when used on-label, according to the applicable directions for use, using high
fidelity tonic stimulation at either ultra-high pulse width or traditional pulse width for
the treatment of persistent or recurrent back and/or leg pain following spinal surgery.


Inclusion Criteria:

- Patients with FBSS defined as persistent or recurrent back and/or leg pain despite one
or more anatomically successful back surgeries for the same original pain.

- Age 18-75 years old at consent.

- Targeted pain intensity of ≥ 5 out of 10 on the Baseline visit NRS.

- ODI score of 41-80 out of 100 at the Baseline visit.

- Appropriate candidate for the surgical procedure and Algovita SCS therapy based on the
clinical judgment of the investigator and the Algovita Instructions for Provider (IFP)
in the Nuvectra product manuals.

- On stable pain medications for at least 28 days prior to consent. Stable is defined as
no new or discontinued pain medications and no changes to total daily dose of any pain
medications.

- Willing and capable of providing informed consent.

- Willing and able of complying with the study-related requirements, procedures, and
visits.

- Speaks English as a primary language (as the Algovita patient manuals are only
currently available in English).

- Has adequate cognitive ability to use the subject devices (e.g., PPC, PoP), as
determined by the investigator.

Exclusion Criteria:

- Has a medical/psychological/psychiatric condition/disorder that could interfere with
study procedures as determined by the investigator.

- Has a coexisting pain condition that might confound pain ratings, as determined by the
investigator.

- Has a condition currently requiring or likely to require the use of MRI or diathermy.

- Has an existing drug pump, SCS System, or other active implantable device.

- Has any prior SCS experience.

- Pregnant or planning to become (if female and sexually active, subject must be using a
reliable form of birth control, be surgically sterile, or be at least 2 years
postmenopausal).

- For subjects with diabetes, HbA1c ≥ 8.5% as measured at the Baseline visit (or within
the 3 months prior to the Baseline visit).

- Participating in another clinical trial that could affect the outcomes or requirements
of this study as determined by the investigator.

- Involved in an injury claim under current litigation or have a pending or approved
workers compensation claim.
We found this trial at
9
sites
Columbus, Ohio 43219
Principal Investigator: Gladstone McDowell, MD
Phone: 614-383-6450
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Chillicothe, Ohio 45601
Principal Investigator: Mark Malinowski, DO
?
mi
from
Chillicothe, OH
Click here to add this to my saved trials
2049 E 100th St
Cleveland, Ohio 44106
(216) 444-2200
Principal Investigator: Robert Bolash, MD
Phone: 216-444-1292
Cleveland Clinic Foundation The Cleveland Clinic (formally known as The Cleveland Clinic Foundation) is a...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Newport Beach, California 92660
Principal Investigator: Rick Paicius, MD
Phone: 949-644-5800
?
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Overland Park, Kansas 66210
Principal Investigator: Srinivas Nalamachu, MD
Phone: 913-396-6278
?
mi
from
Overland Park, KS
Click here to add this to my saved trials
Providence, Rhode Island 02903
Principal Investigator: Alexios Carayannopoulos, MD
Phone: 401-793-9177
?
mi
from
Providence, RI
Click here to add this to my saved trials
Santa Rosa, California 95401
Principal Investigator: Michael Yang, MD
Phone: 707-623-9803
?
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
1811 East Bert Kouns Industrial Loop
Shreveport, Louisiana 71105
Principal Investigator: John Noles, MD
Phone: 318-212-3796
?
mi
from
Shreveport, LA
Click here to add this to my saved trials
Tucson, Arizona 85712
Principal Investigator: Efrain Cubillo, MD
Phone: 520-318-6035
?
mi
from
Tucson, AZ
Click here to add this to my saved trials